Sarakbi et al. (Al Sarakbi et al., 2009) analyzed the expression of SETD2 mRNA in a long-term follow-up cohort of breast cancer patients and found that SETD2 expression levels were significantly reduced in samples from patients who developed metastasis, local recurrence, or died of BC. The gene discussed is SETD2; the disease is breast cancer.